Log on / register
Feedback | Support | My details
CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum.
Isinger A, Bhat M, Borg A, Nilbert M
BMC Cancer 2006, 6:64
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article    
CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer
Margolin S, Eiberg H, Lindblom A, Bisgaard ML
BMC Cancer 2007, 7:163 (17 August 2007)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.